CAPRICOR THERAPEUTICS, INC. Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Capricor Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
  • Capricor Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $453K, a 4.4% decline year-over-year.
  • Capricor Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $2.04M, a 25.9% increase year-over-year.
  • Capricor Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $1.79M, a 164% increase from 2022.
  • Capricor Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $678K, a 26% decline from 2021.
  • Capricor Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $916K, a 2680% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.